Can hENT1 Predict Survival in Locally Advanced Pancreatic Carcinoma Received Gemcitabine Monotherapy?
نویسندگان
چکیده
منابع مشابه
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.
BACKGROUND Human equilibrative nucleoside transporter 1 (hENT1) levels in pancreatic adenocarcinoma may predict survival in patients who receive adjuvant gemcitabine after resection. METHODS Microarrays from 434 patients randomized to chemotherapy in the ESPAC-3 trial (plus controls from ESPAC-1/3) were stained with the 10D7G2 anti-hENT1 antibody. Patients were classified as having high hENT1...
متن کاملPredictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
BACKGROUND To evaluate the predictors for resectability and survival of patients with locally advanced pancreatic cancer (LAPC) treated with gemcitabine-based neoadjuvant therapy (GBNAT). METHODS Between May 2003 and Dec 2009, 41 tissue-proved LAPC were treated with GBNAT. The location of pancreatic cancer in the head, body and tail was 17, 18 and 6 patients respectively. The treatment respon...
متن کاملNeoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
INTRODUCTION To evaluate efficacy and secondary resectability in patients with locally advanced pancreatic cancer (LAPC) treated with neoadjuvant chemoradiotherapy (CRT). PATIENTS AND METHODS A total of 215 patients with locally advanced pancreatic cancer were treated with chemoradiation at a single institution. Radiotherapy was delivered with a median dose of 52.2 Gy in single fractions of 1...
متن کاملPretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study
BACKGROUND Intratumoural heterogeneity has been demonstrated to be a strong indicator of malignant transformation. Our study was to investigate pretreatment (18)F-FDG parameters, including (18)F-FDG based heterogeneity for predicting survival in patients with locally advanced nasopharyngeal carcinoma (NPC). METHODS Forty newly diagnosed, biopsy-proven locally advanced NPC patients who underwe...
متن کاملGemcitabine and 5-Fluorouracil for Advanced Pancreatic Carcinoma
Pancreatic carcinoma is one of the most malignant tumors of alimentary system,and its incidence rate had a tendency to rise in the past decades (Hua et al., 2009; Tuli et al., 2012; Zhou et al., 2012). Early diagnosis of pancreatic carcinoma is still difficult, the majority patients with pancreatic carcinoma are in an advanced stage at the time of diagnosis (Ikeda et al.,2009; Klauss et al., 20...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Madridge Journal of Oncogenesis
سال: 2018
ISSN: 2641-5267
DOI: 10.18689/mjo-1000108